DSOL OTC
Drug Free Solution, Inc.
1W: +0.0%
1M: +0.0%
3M: +100.0%
YTD: -63.6%
1Y: -63.6%
3Y: +300.0%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$383K
+4.6% ▲
Capital Expenditures
$37K
-95.9% ▼
Free Cash Flow
-$420K
+0.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$10K
+294.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2012 | FY2016 | FY2018 | FY2019 |
|---|---|---|---|---|
| — Operating Activities — | ||||
| Net Income | -$756K | -$67K | -$1M | -$1M |
| Depreciation & Amort. | $972 | $8K | $6K | $12K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in Working Capital | $63K | -$195 | $0 | $77K |
| Other Non-Cash Items | -$19K | $53K | $1M | $935K |
| Operating Cash Flow | -$692K | -$22K | -$402K | -$383K |
| — Investing Activities — | ||||
| Capital Expenditures | $0 | $0 | -$19K | -$37K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$19K | -$37K |
| — Financing Activities — | ||||
| Net Debt Issuance | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Financing | $377K | $22K | $423K | $0 |
| Financing Cash Flow | $685K | $22K | $423K | $430K |
| Net Change in Cash | -$7K | $0 | $3K | $10K |
| Cash End of Period | $8K | $8K | $3K | $13K |
| Free Cash Flow | -$692K | -$22K | -$420K | -$420K |